A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia

This study is ongoing, but not recruiting participants.

Study NCT00566631. Last updated on June 12, 2008. Information provided by Janssen-Cilag International NV

Please refer to this study by its ClinicalTrials.gov identifier: NCT00566631

Sponsors and Collaborators

Janssen-Cilag International NV

Investigators


Study Director:	Janssen-Cilag International NV Clinical Trial	Janssen-Cilag International NV